Source:http://linkedlifedata.com/resource/pubmed/id/16196024
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2005-10-13
|
pubmed:abstractText |
1-(2,6-Difluorobenzyl)-3-[(2R)-amino-2-phenethyl]-5-(2-fluoro-3-methoxyphenyl)-6-methyluracil (6), a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor, exists as a pair of atropisomers in solution, which was detected by NMR spectroscopy, and separable by HPLC. In addition to a (R)-configured benzylamine, there is a second stereogenic element due to the presence of a chiral axis between the substituted 5-phenyl group and the uracil core. The rate constant of the interconversion (k = 5.07 x 10(-5) s(-1)) of these two atropisomers was determined by proton NMR analysis of a diastereoisomer-enriched sample in aqueous solution at 25 degrees C, and the corresponding Gibbs free energy DeltaG(#) of rotation barrier (97.4 kJ mol(-1)) was calculated using the Eyring equation. The diastereoisomer half-life at physiological temperature (37 degrees C) in aqueous media was estimated to be about 46 min.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-(2-amino-2-phenylethyl)-1-(2,6-dif...,
http://linkedlifedata.com/resource/pubmed/chemical/6-methyluracil,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, LHRH,
http://linkedlifedata.com/resource/pubmed/chemical/Thymine,
http://linkedlifedata.com/resource/pubmed/chemical/Uracil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0899-0042
|
pubmed:author |
pubmed-author:AllsoppEricE,
pubmed-author:BokserAllanA,
pubmed-author:GrossTimothy DTD,
pubmed-author:GuoZhiqiangZ,
pubmed-author:LingNicholasN,
pubmed-author:MeslehMichael FMF,
pubmed-author:StruthersR ScottRS,
pubmed-author:TucciFabio CFC,
pubmed-author:VajPP,
pubmed-author:XXX,
pubmed-author:ZhuYun-FeiYF
|
pubmed:copyrightInfo |
Copyright 2005 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
559-64
|
pubmed:meshHeading |
pubmed-meshheading:16196024-Chromatography, High Pressure Liquid,
pubmed-meshheading:16196024-Humans,
pubmed-meshheading:16196024-Magnetic Resonance Spectroscopy,
pubmed-meshheading:16196024-Molecular Structure,
pubmed-meshheading:16196024-Receptors, LHRH,
pubmed-meshheading:16196024-Stereoisomerism,
pubmed-meshheading:16196024-Thymine,
pubmed-meshheading:16196024-Uracil
|
pubmed:year |
2005
|
pubmed:articleTitle |
Atropisomeric property of 1-(2,6-difluorobenzyl)-3-[(2R)-amino-2-phenethyl]-5-(2-fluoro-3-methoxyphenyl)-6-methyluracil.
|
pubmed:affiliation |
Department of Medicinal Chemistry, Neurocrine Biosciences, Inc., San Diego, CA 92130, USA.
|
pubmed:publicationType |
Journal Article
|